Technetium (99mTc) votumumab

Technetium (99mTc) votumumab (trade name HumaSPECT) is a human monoclonal antibody labelled with the radionuclide technetium-99m.[1] It was developed for the detection of colorectal tumors, but has never been marketed.[2]

Technetium (99mTc) votumumab
Monoclonal antibody
TypeWhole antibody
SourceHuman
Targettumor antigen CTAA16.88
Clinical data
ATC code
Legal status
Legal status
  • not marketed
Identifiers
CAS Number
ChemSpider
  • none
 NY (what is this?)  (verify)

The target of votumumab is CTAA16.88, a complex of cytokeratin polypeptides in the molecular weight range of 35 to 43 kDa, which is expressed in colorectal tumors.[3]

References
  1. WHO Drug Information
  2. EMA: Public Statement on HumaSPECT Archived 2007-06-10 at the Wayback Machine
  3. EMA: Summary of Product Characteristics for HumaSPECT


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.